Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Tropomyosin 2 antibody. C-terminal. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
TMSB, TPM2, Tropomyosin beta chain, Beta-tropomyosin, Tropomyosin-2
- IP
Supplier Data
Immunoprecipitation - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (AB180176)
Western blot analysis on immunoprecipitation pellet from Human fetal muscle lysate labeling Tropomyosin 2 using ab180176 at 1/10.
All lanes:
Immunoprecipitation - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (ab180176)
Predicted band size: 33 kDa
true
- WB
Supplier Data
Western blot - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (AB180176)
All lanes:
Western blot - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (ab180176) at 1/1000 dilution
Lane 1:
Fetal heart lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
HT-1080 cell lysate at 10 µg
Lane 4:
Fetal muscle lysate at 10 µg
Secondary
All lanes:
Standard HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 33 kDa
true
- WB
Supplier Data
Western blot - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (AB180176)
Blocking buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Tropomyosin 2 antibody [EPR12846] - C-terminal (ab180176) at 1/1000 dilution
Lane 1:
MYC and DDK-tagged Recombinant Human TPM1 protein (Full length)
Lane 2:
MYC and DDK-tagged Recombinant Human TPM2 protein (Full length)
Lane 3:
MYC and DDK-tagged Recombinant Human TPM3 protein (Full length)
Lane 4:
GST-tagged Recombinant Human TPM4 protein (Full length)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 33 kDa
Observed band size: 42 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-Tropomyosin 2 antibody [EPR12846] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TPM2 ensures proper muscle contraction by regulating the interaction between actin and myosin two key components in muscle movement. It forms a complex with actin and troponin a critical protein that regulates muscle contraction through calcium ion binding. This complex facilitates muscle fiber contraction by exposing the binding sites for myosin on actin filaments. The presence of TPM2 in the complex is essential for the contraction mechanism allowing precise control of muscle movements.
Pathways
TPM2 acts in the regulation of muscle contraction and actin cytoskeleton signaling pathways. In the muscle contraction pathway TPM2 interacts closely with tropomyosin 1 (TPM1) and the myosin motor protein playing a regulatory role. It is involved in the actin cytoskeleton signaling pathway where it helps organize actin filaments necessary for various cellular activities. Through these pathways TPM2 integrates signals essential for muscle activity and cellular architecture maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Experimental dermatology 27:1112-1119 PubMed30019485
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com